1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Cambrex Karlskoga AB Acquires ProSyntest AS

M&A Deal Summary

Cambrex Karlskoga AB Acquires ProSyntest AS

On January 7, 2008, Cambrex Karlskoga AB acquired life science company ProSyntest AS

Acquisition Highlights
  • This is Cambrex Karlskoga AB’s 1st transaction in the Life Science sector.
  • This is Cambrex Karlskoga AB’s 1st transaction in the United States.

M&A Deal Summary
Date 2008-01-07
Target ProSyntest AS
Sector Life Science
Buyer(s) Cambrex Karlskoga AB
Deal Type Add-on Acquisition

Target

ProSyntest AS

United States
ProSyntest AS is an active pharmaceutical ingredients (API) research and development company has strengths in cost effective chemical route selection and sample generation, rapid scale up of products at kilo lab scale, as well as chiral and organometallic chemistries.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cambrex Karlskoga AB

Karlskoga, Sweden
Category Company
Sector Life Science
DESCRIPTION

Cambrex Karlskoga AB is a manufacturer of pharmaceuticals products.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2008 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal